Pegasus Materials creates high‑performance polymers from bio‑derived monomers, using AI‑driven screening to meet mechanical, thermal, and dielectric requirements for sectors like electronics, aerospace, and additive manufacturing. The polymers are formulated to be compatible with existing manufacturing equipment and are produced through contract manufacturing partners for scalable supply.
Funding
Funding not disclosed
Founders
Product
Problem
Industries such as electronics, aerospace, defense, and additive manufacturing require high‑performance polymers that meet strict technical specifications while also reducing environmental impact. Conventional petro‑based polymers struggle to deliver both performance and sustainability, limiting the ability of companies to innovate responsibly.
Solution
Pegasus Materials develops next‑generation polymers derived from biological monomers to provide the required mechanical, thermal, and electrical properties for demanding applications. By combining polymer chemistry with biology and leveraging machine‑learning tools to identify optimal bio‑based building blocks, the company creates materials that match or exceed the performance of traditional plastics. These polymers are produced in partnership with contract manufacturers, enabling scalable supply and rapid integration into existing production lines. The result is a portfolio of sustainable, high‑performance polymers that help customers meet both technical and environmental goals.
Target Audience
Primary customers are manufacturers and product developers in electronics, aerospace, defense, additive manufacturing, biomedical, and automotive sectors seeking high‑performance, sustainable polymer solutions.
Features
- Bio‑derived monomers selected through AI‑driven screening to achieve target strength, heat resistance, and dielectric properties
- Tailorable polymer formulations for electronics, aerospace, defense, 3D printing, biomedical, and automotive applications
- Data‑science‑guided material design process that starts with detailed customer need analysis
- Compatibility with existing manufacturing equipment and supply chains via CMO partnerships
- Scalable production pathway that transitions from initial pilot batches to full bio‑monomer substitution after performance validation